Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model

Neurosurgery

Volumn 64, Issue 6, 2009, Pages 1155-1159

  Hänggi, Daniel ^a   Eicker, Sven ^a   Beseoglu, Kerim ^a   Rapp, Marion ^a   Perrin, Jason ^a   Nawatny, Jens ^a   Turowski, Bernd ^a   Sommer, Clemens ^b   Steiger, Hans Jakob ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Animal model; Cerebral vasospasm; Intrathecal nimodipine therapy; Subarachnoid hemorrhage

Indexed keywords

NIMODIPINE; OXIDIZED REGENERATED CELLULOSE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN VASOSPASM; CONTINUOUS INFUSION; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DOSE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; NISSL SUBSTANCE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CEREBRAL ANGIOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CONTAMINATION; MALE; NIMODIPINE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 68049108335     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000340685.06407.FD     Document Type: Article

References (44)

1. Aladag MA, Turkoz Y, Sahna E, Parlakpinar H, Gul M: The attenuation of vaso-spasm by using a sod mimetic after experimental subarachnoidal haemorrhage in rats. Acta Neurochir (Wien) 145:673-677, 2003. (Pubitemid 37094011)
2. Amin-Hanjani S, Ogilvy CS, Barker FG 2nd: Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 54:326-335, 2004. (Pubitemid 38209400)
3. Auer LM, Ito Z, Suzuki A, Ohta H: Prevention of symptomatic vasospasm by topically applied nimodipine. Acta Neurochir (Wien) 63:297-302, 1982. (Pubitemid 12066217)
4. Barker FG 2nd, Ogilvy CS: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A metaanalysis. J Neurosurg 84:405-414, 1996.
5. Barth M, Capelle HH, Weidauer S, Weiss C, Münch E, Thomé C, Luecke T, Schmiedek P, Kasuya H, Vajkoczy P: Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: A prospective, randomized, double-blind phase IIa study. Stroke 38:330-336, 2007. (Pubitemid 46188258)
6. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H: Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 17:472-476, 1986. (Pubitemid 16085691)
7. Boullin DJ, Aitken V, du Boulay GH, Tagari P: The calibre of cerebral arteries of the rat studied by carotid angiography: A model system for studying the aetiology of human cerebral arterial constriction after aneurysmal rupture. Neuroradiology 21:245-252, 1981. (Pubitemid 11047053)
8. Delgado TJ, Brismar J, Svendgaard NA: Subarachnoid haemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 16:595-602, 1985. (Pubitemid 15007231)
9. Gioia AE, White RP, Bakhtian B, Robertson JT: Evaluation of the efficacy of intrathecal nimodipine in canine models of chronic cerebral vasospasm. J Neurosurg 62:721-728, 1985. (Pubitemid 15091453)
10. Grasso G: An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage. Brain Res Brain Res Rev 44:49-63, 2004.
11. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786-790, 1995.
12. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America. J Neurosurg 86:467-474, 1997. (Pubitemid 27097093)
13. Hänggi D, Beseoglu K, Turowski B, Steiger HJ: Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. Clin Neurol Neurosurg 110:784-790, 2008.
14. Hänggi D, Liersch J, Turowski B, Yong M, Steiger HJ: The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: Results of a single center prospective Phase II trial. J Neurosurg 108:1192-1199, 2008. (Pubitemid 351798496)
15. Hänggi D, Turowski B, Perrin J, Rapp M, Liersch J, Sabel M, Steiger HJ: The effect of an intracisternal nimodipine slow-release system on cerebral vasospasm after experimental subarachnoid haemorrhage in the rat. Acta Neurochir (Wien) 104:103-107, 2008.
16. Herdegen T, Leah JD: Inducible and constitutive transcription factors in the mammalian nervous system: Control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 28:370-490, 1998. (Pubitemid 29012678)
17. Hop JW, Rinkel GJ, Algra A, van Gijn J: Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 28:660-664, 1997. (Pubitemid 27118394)
18. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18-36, 1990. (Pubitemid 20206379)
19. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T: Application of nicardipine prolonged-release implants: Analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 56:895-902, 2005. (Pubitemid 40628076)
20. Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH: Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 100:215-224, 2004.
21. Lanzino G, Kassell NF: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 90:1018-1024, 1999. (Pubitemid 29241167)
22. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 90:1011-1017, 1999. (Pubitemid 29241166)
23. Lewis PJ, Weir BK, Nosko MG, Tanabe T, Grace MG: Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm. Neurosurgery 22:492-500, 1988. (Pubitemid 18095951)
24. Link TE, Murakami K, Beem-Miller M, Tranmer BI, Wellman GC: Oxyhemoglobin-induced expression of R-Type Ca2+ channels in cerebral arteries. Stroke 39:2122-2128, 2008.
25. Longo M, Blandino A, Ascenti G, Ricciardi GK, Granata F, Vinci S: Cerebral angiography in the rat with mammographic equipment: A simple, cost-effective method for assessing vasospasm in experimental subarachnoid haemorrhage. Neuroradiology 44:689-694, 2002. (Pubitemid 36075932)
26. Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J: Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. Intensive Care Med 34:932-938, 2008. (Pubitemid 351571198)
27. Megyesi JF, Vollrath B, Cook DA, Findlay JM: In vivo animal models of cerebral vasospasm: A review. Neurosurgery 46:448-461, 2000. (Pubitemid 30094483)
28. Ono S, Date I, Nakajima M, Onoda K, Ogihara K, Shiota T, Asari S, Ninomiya Y, Yabuno N, Ohmoto T: Three-dimensional analysis of vasospastic major cerebral arteries in rats with the corrosion cast technique. Stroke 28:1631-1638, 1997. (Pubitemid 27349694)
29. Prunell GF, Mathiesen T, Svendgaard NA: Experimental subarachnoid hemorrhage: Cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery 54:426-437, 2004. (Pubitemid 38209412)
30. Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J: Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 25:CD000277, 2005.
31. Rinkel GJ, Feigin VL, Algra A, van Gijn J: Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 18:CD000483, 2004.
32. Satoh M, Parent AD, Zhang JH: Inhibitory effect with antisense mitogen-activated protein kinase oligodeoxynucleotide against cerebral vasospasm in rats. Stroke 33:775-781, 2002. (Pubitemid 34204006)
33. Sommer C: Ischemic preconditioning: Postischemic structural changes in the brain. J Neuropathol Exp Neurol 67:85-92, 2008.
34. Suarez JI, Tarr RW, Selman WR: Aneurysmal subarachnoid hemorrhage. N Engl J Med 354:387-396, 2006.
35. Tani E, Matsumoto T: Continuous elevation of intracellular Ca2+ is essential for the development of cerebral vasospasm. Curr Vasc Pharmacol 2:13-21, 2004. (Pubitemid 38855011)
36. Treggiari MM, Walder B, Suter PM, Romand JA: Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-984, 2003. (Pubitemid 36460888)
37. Treggiari-Venzi MM, Suter PM, Romand JA: Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery 48:249-262, 2001.
38. Turowski B, Hänggi D, Beck A, Aurich V, Steiger HJ, Moedder U: New angiographic measurement tool for analysis of small cerebral vessels: Application to a subarachnoid haemorrhage model in the rat. Neuroradiology 49:129-137, 2007. (Pubitemid 46218585)
39. Vatter H, Weidauer S, Konczalla J, Dettmann E, Zimmermann M, Raabe A, Preibisch C, Zanella FE, Seifert V: Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: Clinical and neuroradiological assessment of the rat double hemorrhage model. Neurosurgery 58:1190-1197, 2006. (Pubitemid 43879554)
40. Verlooy J, Van Reempts J, Haseldonckx M, Borgers M, Selosse P: The course of vasospasm following subarachnoid haemorrhage in rats. A vertebrobasilar angiographic study. Acta Neurochir (Wien) 117:48-52, 1992.
41. Voldby B, Petersen OF, Buhl M, Jakobsen P, Ostergaard R: Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine). Acta Neurochir (Wien) 70:243-254, 1984. (Pubitemid 14167319)
42. Wellman GC: Ion channels and calcium signaling in cerebral arteries following subarachnoid hemorrhage. Neurol Res 28:690-702, 2006. (Pubitemid 44656095)
43. Weyer GW, Nolan CP, Macdonald RL: Evidence-based cerebral vasospasm management. Neurosurg Focus 21:E8, 2006.
44. Zabramski JM, Spetzler RF, Bonstelle C: Chronic cerebral vasospasm: Effect of volume and timing of hemorrhage in a canine model. Neurosurgery 18:1-6, 1986.